HUM

Humana
D

HUM

Arincen41/100B

Humana earnings

Humana reports its Q4 FY2026 results on 10 February 2027, before the market opens. Analysts expect earnings per share of -7.60 USD and revenue of 41.35B USD.

In Q3 FY2026, reported on 6 November 2026, Humana reported EPS of -0.70 USD against the -1.00 USD analysts expected (+30.0%), on revenue of 41.16B USD against 40.87B USD (+0.7%).

Last EPS surprise
+30.0%
Last revenue surprise
+0.7%
Move after the last report
+5.3%
Average move after earnings
3.8%

EPS and revenue against estimates

Next earnings · Q4 FY2026
EPS estimate
-7.60 USD
Revenue estimate
41.35B USD
Last quarter · Q3 FY2026
EPS-0.70Beat +30.0%Revenue41.16BBeat +0.7%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growthNext-day move
Q3 FY20271.73———43.91B——+6.69%—
Q2 FY20279.60——+26.16%43.80B——+7.17%—
Q1 FY202713.30——+29.04%43.16B——+8.86%—
Q4 FY2026-7.60———41.35B——+27.16%—
Q3 FY2026-1.00-0.70+30.00%-121.60%40.87B41.16B+0.69%+26.05%+5.3%
Q2 FY20267.277.61+4.68%+21.37%40.58B40.87B+0.71%+26.18%-6.1%
Q1 FY202610.2410.31+0.68%-10.97%39.37B39.65B+0.70%+23.47%+6.0%
Q4 FY2025-4.00-3.96+1.00%—32.04B32.52B+1.47%+11.30%-3.2%
Q3 FY20252.933.24+10.58%-22.12%32.00B32.65B+2.04%+11.06%-6.0%
Q2 FY20255.926.27+5.91%-9.91%31.87B32.39B+1.62%+9.64%+12.5%
Q1 FY202510.0711.58+15.00%+60.17%32.20B32.11B-0.27%+8.45%+1.0%
Q4 FY2024-2.23-2.16+3.14%—28.81B29.21B+1.40%+10.40%-3.5%
Q3 FY20243.404.16+22.35%-46.53%28.68B29.40B+2.50%+11.26%+3.3%
Q2 FY20245.856.96+18.97%-22.15%28.52B29.54B+3.56%+10.44%-10.5%
Q1 FY20246.127.23+18.14%-22.92%28.52B29.61B+3.81%+10.73%-3.6%
Q4 FY2023-0.07-0.11-57.14%-106.79%25.54B26.46B+3.61%+17.93%-11.7%
Q3 FY20237.167.78+8.66%+13.08%25.55B26.42B+3.40%+15.90%-6.6%
Q2 FY20238.828.94+1.36%+3.11%26.23B26.75B+1.97%+13.04%+5.6%
Q1 FY20239.279.38+1.19%+16.67%26.19B26.74B+2.09%+11.56%+0.8%
Q4 FY20221.461.62+10.96%+30.65%22.48B22.44B-0.18%+6.58%+0.3%
Q3 FY20226.286.88+9.55%+42.44%22.82B22.80B-0.07%+10.16%+0.9%
Q2 FY20227.678.67+13.04%+25.83%23.45B23.66B+0.92%+14.61%-2.6%
Q1 FY20226.788.04+18.58%+4.82%23.54B23.97B+1.85%+15.98%+2.8%
Q4 FY20211.231.24+0.81%—23.38B21.05B-9.95%+10.45%+3.0%
Q3 FY20214.614.83+4.77%+56.82%20.88B20.70B-0.87%+3.10%+0.6%
Q2 FY20216.866.89+0.44%-45.14%20.86B20.65B-1.04%+8.19%-5.8%
Q1 FY20217.067.67+8.64%+42.04%18.88B20.67B+9.46%+9.15%-2.2%
Q4 FY2020-2.35-2.30+2.13%-200.88%19.63B19.06B-2.87%+16.98%+0.8%
Q3 FY20202.863.08+7.69%-38.77%116.78M20.08B+17,090.56%+23.61%—
Q2 FY202010.2712.56+22.30%+107.60%15.54B19.08B+22.79%+17.47%—
Q1 FY20204.845.40+11.57%+20.54%16.28B18.94B+16.30%+17.56%—
Q4 FY20192.202.28+3.64%-13.96%15.58B16.30B+4.60%+15.01%—
Q3 FY20194.585.03+9.83%+9.83%14.66B16.24B+10.75%+14.32%—
Q2 FY20195.316.05+13.94%+52.78%14.16B16.25B+14.74%+13.93%—
Q1 FY20194.304.48+4.19%+33.33%15.36B16.11B+4.84%+12.80%—
Q4 FY20182.532.65+4.74%+28.64%13.43B14.17B+5.46%+7.42%—
Q3 FY20184.264.58+7.51%+35.10%13.11B14.21B+8.37%+6.96%+6.6%
Q2 FY20183.793.96+4.49%+13.47%13.45B14.26B+5.98%+5.36%+1.2%
Q1 FY20183.193.36+5.33%+22.18%13.42B14.28B+6.38%+3.76%-2.6%
Q4 FY20172.002.06+3.00%-1.44%12.72B13.19B+3.70%+2.41%-1.7%
Q3 FY20173.273.39+3.67%+6.60%12.71B13.28B+4.49%-3.01%-5.1%
Q2 FY20173.083.49+13.31%+51.74%11.85B13.53B+14.16%-3.38%+4.3%
Q1 FY20172.552.75+7.84%+47.85%12.41B13.76B+10.89%-0.28%-0.7%
Q4 FY20162.062.09+1.46%+44.14%12.54B12.88B+2.73%-3.61%+2.3%
Q3 FY20163.153.18+0.95%+47.22%13.47B13.69B+1.67%+2.48%+1.1%
Q2 FY20162.232.30+3.14%+37.72%13.55B14.01B+3.38%+2.00%+2.3%
Q1 FY20161.811.86+2.76%-24.70%13.33B13.80B+3.51%-0.24%-0.7%
Q4 FY20151.461.45-0.68%+33.03%13.23B13.36B+1.03%+8.38%+1.0%
Q3 FY20152.132.16+1.41%+16.76%13.05B13.36B+2.40%+9.19%-1.0%
Q2 FY20151.631.67+2.45%-23.74%13.29B13.73B+3.30%+12.35%-0.1%
Q1 FY20152.562.47-3.52%+5.11%14.24B13.83B-2.85%+18.11%-7.2%
Q4 FY20141.161.09-6.03%+36.25%13.01B12.33B-5.27%+21.02%+1.3%
Q3 FY20142.001.85-7.50%-19.91%13.13B12.24B-6.78%+18.60%-6.6%
Q2 FY20142.192.190.00%-20.36%12.13B12.22B+0.76%+18.42%-5.6%
Q1 FY20141.942.35+21.13%-12.64%9.59B11.71B+22.08%+11.69%+8.4%
Q4 FY20130.930.80-13.98%-32.77%11.86B10.19B-14.08%+6.59%-1.8%
Q3 FY20132.152.31+7.44%-11.83%9.60B10.32B+7.44%+6.92%+2.0%
Q2 FY20132.472.75+11.34%+25.57%9.27B10.32B+11.34%+6.41%+2.2%
Q1 FY20131.812.69+48.62%+80.54%7.06B10.49B+48.62%+2.61%+4.7%
Q4 FY20121.071.19+11.21%-0.83%8.59B9.56B+11.21%+5.53%+4.7%
Q3 FY20122.052.62+27.80%-1.87%7.55B9.65B+27.80%+3.76%+0.4%
Q2 FY20122.282.19-3.95%-19.19%10.10B9.70B-3.95%+4.47%+0.0%
Q1 FY20121.531.49-2.61%-19.89%10.49B10.22B-2.61%+11.18%-8.1%
Q4 FY20111.201.200.00%+90.48%9.06B9.06B+0.01%+8.46%-5.4%
Q3 FY20112.022.67+32.18%+15.09%7.04B9.30B+32.18%+11.38%+5.7%
Q2 FY20112.062.71+31.55%+6.27%7.06B9.28B+31.55%+8.09%-3.0%
Q1 FY20111.861.860.00%+22.37%9.19B9.19B0.00%+9.67%+0.5%
Q4 FY20100.810.63-22.22%-57.43%10.64B8.35B-21.52%+9.40%-3.0%
Q3 FY20101.662.32+39.76%+30.34%5.98B8.35B+39.76%+8.22%+0.7%
Q2 FY20101.672.55+52.69%+52.69%5.62B8.59B+52.70%+8.74%+3.6%
Q1 FY20101.141.52+33.33%+24.59%6.29B8.38B+33.34%+8.67%-4.3%
Q4 FY20091.481.480.00%+38.32%60.00M7.63B+12,621.74%+1.94%+0.2%
Q3 FY20091.771.78+0.56%+19.46%63.64M7.72B+12,025.65%+7.96%-1.5%
Q2 FY20091.641.67+1.83%+34.68%60.89M7.90B+12,873.20%+7.46%+2.8%
Q1 FY20091.181.22+3.39%+159.57%53.20M7.71B+14,396.50%+10.80%+6.9%
Q4 FY20081.071.070.00%-25.17%55.00M7.49B+13,513.88%+18.12%+5.8%
Q3 FY20081.471.49+1.36%-16.29%58.21M7.15B+12,180.38%+13.11%-15.1%
Q2 FY20081.181.24+5.08%-3.13%47.58M7.35B+15,349.27%+14.38%+4.9%
Q1 FY20080.450.47+4.44%+11.90%43.09M6.96B+16,053.39%+12.17%+3.3%
Q4 FY20071.321.43+8.33%+55.43%38.77M6.34B+16,250.07%+12.09%-3.5%
Q3 FY20071.491.78+19.46%+87.37%35.99M6.32B+17,457.14%+11.86%-2.4%
Q2 FY20071.171.28+9.40%+141.51%31.08M6.43B+20,579.49%+18.86%+9.8%
Q1 FY20070.400.42+5.00%+7.69%29.52M6.20B+20,916.30%+31.89%-2.6%
Q4 FY20060.880.92+4.55%+100.00%24.87M5.66B+22,639.52%+54.38%+0.9%
Q3 FY20060.970.95-2.06%+58.33%15.32M5.65B+36,788.63%+47.84%-6.2%
Q2 FY20060.350.53+51.43%+3.92%5.28B5.41B+2.35%+52.47%+8.5%
Q1 FY20060.430.39-9.30%-26.42%5.51B4.70B-14.67%+38.89%-0.5%
Q4 FY20050.450.46+2.22%+58.62%4.89M3.66B+74,789.64%+14.13%-2.0%
Q3 FY20050.510.60+17.65%+15.38%3.40B3.82B+12.40%+20.31%+1.1%
Q2 FY20050.510.510.00%+10.87%3.00B3.55B+18.21%+3.35%+7.0%
Q1 FY20050.490.53+8.16%+29.27%2.77B3.39B+22.12%+3.05%+0.3%
Q4 FY20040.270.29+7.41%-29.27%1.86M3.21B+172,268.75%+1.80%-1.4%
Q3 FY20040.440.52+18.18%+36.84%2.54M3.18B+125,025.91%+2.07%+6.3%
Q2 FY20040.390.46+17.95%+24.32%2.54M3.43B+134,812.81%+13.25%+5.1%
Q1 FY20040.410.410.00%+32.26%2.00M3.29B+164,247.45%+12.12%-6.8%
Q4 FY20030.400.41+2.50%+20.59%1.95M3.15B+161,484.69%+10.43%-1.6%
Q3 FY20030.380.380.00%+22.58%2.00M3.11B+155,488.25%+9.51%-0.6%
Q2 FY20030.290.37+27.59%+37.04%2.37B3.03B+27.58%+6.99%+5.1%
Q1 FY20030.310.310.00%+10.71%2.00M2.93B+146,485.80%+7.29%-2.9%
Q4 FY20020.330.34+3.03%+61.90%1.94M2.86B+146,977.41%+8.85%-5.6%
Q3 FY20020.310.310.00%+72.22%3.00B2.84B-5.28%+8.83%-6.5%
Q2 FY20020.270.270.00%+80.00%2.83B2.83B-0.00%+14.64%-4.8%
Q1 FY20020.280.280.00%+75.00%1.00M2.73B+273,158.20%+11.85%-3.2%
Q4 FY20010.200.21+5.00%+31.25%2.50B2.62B+4.96%+2.46%-6.1%
Q3 FY20010.180.180.00%+28.57%2.61B2.61B+0.04%-0.19%+2.5%
Q2 FY20010.150.150.00%+36.36%2.50B2.47B-1.07%-8.37%+8.9%
Q1 FY20010.160.160.00%+23.08%2.46B2.44B-0.85%-7.53%-3.1%
Q4 FY20000.150.16+6.67%+6.67%107.81M2.56B+2,274.49%-0.54%+2.7%
Q3 FY20000.200.14-30.00%+7.69%3.76B2.62B-30.50%+2.31%+4.3%
Q2 FY20000.110.110.00%-35.29%2.00M2.70B+134,700.00%+7.62%-3.4%
Q1 FY20000.150.13-13.33%-35.00%2.31B2.64B+14.49%+6.66%-16.4%
Q4 FY19990.130.15+15.38%-55.88%2.18B2.57B+18.18%+4.25%-7.7%
Q3 FY19990.120.13+8.33%-59.38%2.36B2.56B+8.33%+3.77%-2.3%
Q2 FY19990.170.170.00%-45.16%2.51B2.51B0.00%+2.41%-3.1%
Q1 FY19990.220.20-9.09%-33.33%2.72B2.48B-9.09%+3.12%-2.7%
Q4 FY19980.340.340.00%+17.24%2.47B2.47B0.00%+2.41%-2.0%
Q3 FY19980.320.320.00%+18.52%2.46B2.46B0.00%+25.20%+10.7%
Q2 FY19980.310.310.00%+24.00%2.45B2.45B0.00%+33.22%-6.0%
Q1 FY19980.300.300.00%+25.00%2.40B2.40B0.00%+31.11%-1.4%
Q4 FY19970.300.29-3.33%+52.63%2.49B2.41B-3.23%+32.55%-2.3%
Q3 FY19970.280.27-3.57%+22.73%2.03B1.97B-3.25%+10.50%+2.7%
Q2 FY19970.260.25-3.85%+13.64%1.90B1.84B-3.49%+14.54%+2.7%
Q1 FY19970.230.24+4.35%-25.00%1.75B1.83B+4.72%+15.58%+6.2%
Q4 FY19960.210.19-9.52%-36.67%2.21M1.82B+82,188.10%+21.35%+2.0%
Q3 FY19960.220.220.00%-18.52%—1.78B—+63.10%+9.9%
Q2 FY19960.190.22+15.79%-21.43%—1.60B—+50.23%-0.6%
Q1 FY19960.320.320.00%0.00%—1.59B—+51.82%-2.0%
Q4 FY19950.290.30+3.45%0.00%—1.50B—+57.29%-5.2%
Q3 FY19950.270.270.00%0.00%—1.09B—+18.31%+7.7%
Q2 FY19950.300.28-6.67%+21.74%—1.07B—+17.00%-5.9%
Q1 FY19950.310.32+3.23%+60.00%—1.04B—+20.55%-4.2%
Q4 FY19940.280.30+7.14%+66.67%—953.00M—+20.48%-2.0%
Q3 FY19940.250.27+8.00%+80.00%—923.00M—+18.03%-2.1%
Q2 FY19940.220.23+4.55%+91.67%—912.00M—+17.22%-2.2%
Q1 FY19940.180.20+11.11%——866.00M——-5.1%
Q4 FY19930.160.18+12.50%+50.00%—791.00M——+4.3%
Q3 FY19930.120.15+25.00%-62.50%—782.00M—-19.71%+2.7%
Q2 FY19930.100.12+20.00%——786.00M——-2.0%
Q2 FY1993—0.12———778.00M——+2.3%
Q4 FY19920.480.12-75.00%-77.78%—-772.00M—-147.54%-1.6%
Q3 FY1992—0.40—-16.67%—974.00M—-37.72%+3.8%
Q1 FY1992—0.48—-15.79%—1.63B——-5.2%
Q4 FY1991—0.54—-3.57%—1.62B——-1.0%
Q3 FY1991—0.48—-33.33%—1.56B—+17.59%+4.1%
Q2 FY1991—0.55—-34.68%————-1.9%
Q1 FY1991—0.57—-32.14%————+1.0%
Q4 FY1990—0.56—-25.33%————+0.3%
Q3 FY1990—0.72———1.33B——+1.5%
Q2 FY1990—0.84———1.28B——+0.8%
Q1 FY1990—0.84———1.27B——-1.9%
Q4 FY1989—0.75———1.19B——-1.3%

The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.

Q3 FY2026

What the market waited for, and what came

From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.

High importanceNot in the report

Medical care costs

ExpectedInsurance benefits cost of 94.3% of premiumsanalysts' consensus
The resultNot in the report

The more Humana spends on members’ care, the less it keeps as profit.

High importanceMet

Full-year profit outlook

ExpectedAbout $9.16 per share in adjusted full-year profit guidanceanalysts' consensus
The resultFull-year adjusted profit guidance of at least $9.50 per share

The outlook will show whether Humana expects to protect profits despite rising care costs.

High importanceNot in the report

Insurance premium growth

ExpectedInsurance premium revenue growth of 26%analysts' consensus
The resultNot in the report

Premium growth shows whether Humana’s main insurance business is bringing in enough revenue to support profits.

Beat record

On average, analysts' EPS estimate was 15.6% off the result, either way, and their revenue estimate 1.9%, over the last 12 quarters.

EPS beats
91 / 135
Revenue beats
90 / 120
Average EPS surprise, last 12
+6.1%
Since
March 1993

See also:Forecast,EPS,Income statement

Common questions about Humana's earnings

Source: Financial Modeling Prep